RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 118 filers reported holding RELMADA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $298,569 | +1.7% | 99,523 | -16.6% | 0.00% | – |
| Q2 2023 | $293,522 | +45336.8% | 119,318 | +64396.2% | 0.00% | – |
| Q4 2022 | $646 | -99.6% | 185 | -95.6% | 0.00% | – |
| Q3 2022 | $155,000 | -87.0% | 4,182 | -93.3% | 0.00% | -100.0% |
| Q2 2022 | $1,191,000 | +26.4% | 62,701 | +79.6% | 0.00% | 0.0% |
| Q1 2022 | $942,000 | +733.6% | 34,905 | +596.2% | 0.00% | – |
| Q4 2021 | $113,000 | -45.4% | 5,014 | -36.5% | 0.00% | – |
| Q3 2021 | $207,000 | +72.5% | 7,901 | +111.5% | 0.00% | – |
| Q2 2021 | $120,000 | +93.5% | 3,735 | +112.2% | 0.00% | – |
| Q1 2021 | $62,000 | -56.9% | 1,760 | -61.0% | 0.00% | – |
| Q4 2020 | $144,000 | +46.9% | 4,508 | +73.5% | 0.00% | – |
| Q3 2020 | $98,000 | -56.2% | 2,599 | -48.2% | 0.00% | – |
| Q2 2020 | $224,000 | +286.2% | 5,022 | +195.4% | 0.00% | – |
| Q1 2020 | $58,000 | +56.8% | 1,700 | +81.6% | 0.00% | – |
| Q4 2019 | $37,000 | – | 936 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Guild Investment Management, Inc. | 205,300 | $615,900 | 1.03% |
| Deep Track Capital, LP | 2,837,818 | $8,513,454 | 0.33% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 974,082 | $2,922,246 | 0.23% |
| apricus wealth, LLC | 77,362 | $239,822 | 0.21% |
| Palo Alto Investors LP | 732,400 | $2,197,200 | 0.21% |
| RTW INVESTMENTS, LP | 2,131,835 | $6,395,505 | 0.14% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $300,000 | 0.09% |
| AdvisorShares Investments LLC | 112,908 | $338,724 | 0.09% |
| Savior LLC | 3,500 | $10,500 | 0.07% |
| Spotlight Asset Group, Inc. | 20,000 | $60,000 | 0.05% |